Velikyan I

Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences.

Velikyan I, Bossart M, Haack T, ..., Wagner M, Eriksson O

Pharmaceuticals (Basel, Switzerland) 16 (1) - [2022-12-31; online 2022-12-31]

Olof Eriksson SciLifeLab Fellow

Improved Radiolytic Stability of a 68Ga-labelled Collagelin Analogue for the Imaging of Fibrosis.

Velikyan I, Rosenström U, Rosestedt M, Eriksson O, Antoni G

Pharmaceuticals (Basel, Switzerland) 14 (10) - [2021-09-28; online 2021-09-28]

Olof Eriksson SciLifeLab Fellow

Automated GMP-Compliant Production of [68Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans.

Wagner M, Doverfjord JG, Tillner J, ..., Eriksson O, Velikyan I

Pharmaceuticals (Basel, Switzerland) 13 (8) 176 [2020-07-31; online 2020-07-31]

Olof Eriksson SciLifeLab Fellow

Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use.

Velikyan I, Rosenstrom U, Eriksson O

American journal of nuclear medicine and molecular imaging 7 (3) 111-125 [2017-07-15; online 2017-07-15]

Olof Eriksson SciLifeLab Fellow

Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible.

Selvaraju RK, Bulenga TN, Espes D, ..., Velikyan I, Eriksson O

American journal of nuclear medicine and molecular imaging 5 (3) 259-269 [2015-02-15; online 2015-02-15]

Olof Eriksson SciLifeLab Fellow

Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.

Velikyan I, Sundberg AL, Lindhe O, ..., Långström B, Tolmachev V

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 46 (11) 1881-1888 [2005-11-00; online 2005-11-05]

Olof Eriksson SciLifeLab Fellow